Utah Medical Products, Inc. (NasdaqGS: UTMD)
Health Care · Health Care Equipment & Supplies · US
$74.54
+0.90% today · +18.4% 1Y
Utah Medical Products, Inc. (NasdaqGS: UTMD) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $237.32M and employs 146 people.
Over the last twelve months the share price has gained 18.4%, trading between 53.66 and 76.89.
Tweenvest scores Utah Medical Products, Inc. across four factors: quality 85/100, value 23/100, growth 0/100, dividend 44/100. Its strongest factor is quality.
UTMD price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $237.32M
- Revenue (TTM)
- $36.11M
- P/E
- 22.71
- EPS
- 3.28
- Dividend yield
- 1.68%
- Beta (5Y)
- 0.39
- 52-week high
- $76.89
- 52-week low
- $53.66
- Avg volume (3M)
- —
- Shares outstanding
- 3.18M
- Employees
- 146
- Next earnings
- —
About Utah Medical Products, Inc.
Utah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.
- ISIN
- US9174881089
- Founded
- 1978
- Listed since
- Mar 8, 1999
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Prim, S.A.BME: PRM | $241.86M | €12.60 | -0.79% |
| AVE Science&Technology CO.,LTDSHSE: 688067 | $241.77M | CN¥24.07 | -1.84% |
| Acotec Scientific Holdings LimitedSEHK: 6669 | $239.21M | HK$5.99 | -0.91% |
| Acme United CorporationNYSEAM: ACU | $238.27M | $62.15 | -2.13% |
| Bioteque CorporationTPEX: 4107 | $237.32M | NT$109.50 | -0.45% |
| ANGEL ROBOTICS Co., Ltd.KOSDAQ: A455900 | $234.72M | ₩20,500.00 | -5.53% |
| Electromed, Inc.NYSEAM: ELMD | $229.47M | $27.69 | -0.40% |
| Stille ABOM: STIL | $224.20M | Skr250.00 | +0.20% |
Figures last refreshed Oct 11, 2026.